BLIS K12 Receives “No Objection” GRAS Letter From FDA

635914720924384696taste.jpg

19 Feb 2016 --- Oral-health probiotic BLIS K12 has received a “Letter of No Objection” from the US Food and Drink Administration (FDA) for its self-affirmed notification of Generally Recognized As Safe (GRAS) status.

The patented probiotic strain of Streptococcus salivarius, BLIS K12, has been studied for benefits to ear and throat health in children and adults, including reducing incidence of halitosis and Streptococal pharyngitis.
 
BLIS K12 developer Blis Technologies (Dunedin, New Zealand) and North America distributor Stratum Nutrition (Saint Charles, MO) celebrated the “No Objection” GRAS status as key to opening more markets for the probiotic:
 
“It adds a new level of credibility for BLIS K12 and puts the conversations with larger consumer food and beverage companies in the US on a stronger footing,” said Peter Fennessy, board chairman, Blis Technologies.
 
“Many of those companies are, quite rightly, risk averse. Therefore, having the non-objection notification from the FDA offers an additional level of confidence and makes it clearer where BLIS K12 fits within the category,” Fennessy added.
 
Jeremy Moore, managing director of Stratum Nutrition, added, “Very few ingredients in this space go to this level, so it is a definite feather in the cap for Blis.”
 
Through the GRAS program, companies may submit their determination, supported by research and expert review, that a specific ingredient is Generally Recognized As Safe. The Letter of No Objection means that the FDA has reviewed the data and has no questions regarding the notice submitted.

To contact our editorial team please email us at editorial@cnsmedia.com

Related Articles

Health & Nutrition News

Symprove multi-strain supplement linked to re-balancing of gut microbiome

20 Nov 2018 --- “Good” bacteria in the live probiotic Symprove can successfully reach and colonize the gut, where they can modify existing gut flora, according to new research published in the International Journal of Pharmaceutics. Researchers also noted that these bacteria are capable of modifying the immune response in the human body.

Health & Nutrition News

Navigating the digestive health space: Probiotic strain specificity and microbiome key to future NPD

16 Nov 2018 --- Emerging science linking a healthy microbiome to nearly every facet of health, as well as the ongoing media reporting on probiotics, have helped drive consumer interest in gut health. This growing area offers a wealth of opportunities to formulators, but due to regulatory demands and increasing consumer scrutiny, a clear view of how to navigate this space is vital.

Health & Nutrition News

Kellogg’s debuts gut-boosting cereal with prebiotics, probiotics and fiber

15 Nov 2018 --- Kellogg’s has launched a “3-in-1” cereal aimed at making digestive wellness support easily accessible in food. The new wellness brand HI! Happy Inside delivers prebiotics, probiotics and fiber in an all-in-one cereal. The launch comes at a time when interest in digestive health seems to only continue to grow.

Health & Nutrition News

Experts weigh in on digestive health in Kerry Health and Nutrition Institute webinar

14 Nov 2018 --- Gut health is becoming increasingly popular among consumers. In this wide-ranging health area, the gut-brain axis (GBA) is a key area of interest, along with the sort of probiotic bacteria that aid wider gut health, Dairy & Food Culture Technologies Consultant, Dr. Mary Ellen Sanders, tells NutritionInsight. Sanders will be presenting a Kerry Health and Nutrition Institute webinar today hosted on FoodIngredientsFirst.com.

Packaging & Technology News

Consumer interest in liquid nutraceutical delivery forms grow as “pill fatigue” perseveres, says Bormioli Pharma 

13 Nov 2018 --- Consumers are more mindful of their health and nutraceutical products have become aspects of an everyday diet. This, coupled with a faster pace of consumer living has spurred a number of packaging innovations for nutraceuticals. This is according to Elena Piazza, Business Development & Marketing Manager at Bormioli Pharma, which supplies pharmaceutical and nutraceutical packaging solutions. Its portfolio includes a dual chamber system packaging which offers precise reconstitution for oral products, including food supplements.

More Articles
URL : http://www.nutritioninsight.com:80/news/blis-k12-receives-no-objection-gras-letter-from-fda.html